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Abstract 
Background: This case report presents a case of Vulvar Crohn’s disease (VCD) in an adolescent, that is an uncommon 
manifestation of Crohn’s disease (CD) without gastrointestinal symptoms. Before treating CD itself with proper medi-
cation, vulvar abscess continued to recur without improvement.
Case presentation: We report the case of an 18-year-old woman with VCD. After treatment with azathioprine 50 mg 
daily and mesalazine 1 g three times daily, vulvar lesions resolved after 6 weeks. We collected electronic medical data 
on patient characteristics, and evaluated findings of physical examinations, pelvic MRI, and biopsy specimen obtained 
from gastroduodenoscopy/colonoscopy.
Conclusions: VCD is a rare manifestation of CD that may be misdiagnosed in the absence of gastrointestinal symp-
toms leading to delayed treatment. If a patient has an unexplained vulvar inflammatory lesion and with repeated 
failed surgical treatment, gynecologists should consider the possibility of a VCD.
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Background
Crohn’s disease (CD) commonly manifests as a chronic 
inflammatory bowel disease presenting with gastrointes-
tinal symptoms, such as diarrhea, dyspepsia, and perianal 
complication [1], but also rarely manifests extra-intesti-
nally on the vulva without evidence of intestinal CD [2]. 
The two forms of vulvar Crohn’s disease (VCD) presenta-
tion include lesions that are contiguous with the gastroin-
testinal tract, such as fistulas and fissures; the other form 
comprises of noncontiguous vulvar lesions, referred to 
as metastatic CD [3]. Unfortunately, due to the rarity of 
VCD, patients may not be diagnosed accurately or diag-
nosis is initially delayed, and the patient may uninten-
tionally receive unsuccessful localized surgical treatment 
[4, 5]. Even incidence of VCD is still unrevealed because 
of its rarity.
We present a case of VCD, an uncommon manifesta-
tion of CD, in an adolescent who did not have any gas-
trointestinal symptoms. Delayed diagnosis led to delayed 
treatment and unnecessary surgical interventions. Rel-
evant literatures were reviewed from search data in 
PubMed using the key words ‘‘vulvar Crohn’s disease, 
metastatic Crohn’s disease, vulvar inflammation.” and a 
brief summary of cases are shown in Table 1  [2–4, 6–12].
We collected electronic medical data on patient char-
acteristics, and evaluated findings of physical examina-
tions, pelvic MRI, and biopsy specimen obtained from 
gastroduodenoscopy/colonoscopy.
Case presentation
An 18-year-old woman without any significant his-
tory of previous illnesses visited an outpatient clinic 
with a chief complaint of recurrent vulvar abscess for 5 
months. On inspection, the vulva was diffusely swelling, 
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tender, red and warm (Fig. 1). The patient had no other 
complaints apart from perineal pain and difficulty in sit-
ting for a long time. She had previously visited another 
hospital with the same complaint, and on 3 occasions 
received incision and drainage (I&D) of the abscess. 
She visited a secondary hospital, where abdominal and 
pelvic computed tomography (APCT) showed a labia 
major abscess and laboratory results showed no abnor-
malities. She received antibiotic treatment, comprising 
of cephalosporin and metronidazole for 2 weeks, but her 
symptoms did not improve. A magnetic resonance imag-
ing (MRI) of the pelvis was performed which revealed a 
9 × 7 mm sized abscess in the right labia major (Fig. 2A). 
Under the impression of persistent vulvar abscess with 
positive culture results implicating Citrobacter freundii, 
Corynebacterium striatum, and Eschericia coli, I&D with 
local excision of inflamed tissues was performed under 
general anesthesia. The pathology results showed acute 
and chronic inflammation with granulation tissue forma-
tion, without indication of caseation status. Intravenous 
antibiotics were administered for 2 weeks and the vul-
var inflammation subsided. However, inflammation and 
painful swelling of the contralateral labia major arose 2 
weeks postoperatively.
She was referred to our institution, a tertiary care hos-
pital. At the pediatric and adolescent gynecology clinic, 
Table 1 Summary of VCD cases in clinical, histological, Imaging findings and management
MRI, magnetic resonance imagning; CT, computed tomography
Clinical presentation Asymmetric/symmetric vulvar swelling
Vulvar pain
Aphthoid or linear “knife-like” vulvar ulcer (often extends to groin)
Hypertrophic exophytic vulvar lesion/ Scarring, Plaque, Pedunculated tags of tissue
Vulvar abscess with sinus tract




Histological finding of vulvar lesion Noncaseating granuloma
Mixed inflammatory cell infiltrates
Fibrosis









Small volume lymphadenopathy with evidence of fissuring in the perianal region.
Abdomen-Pelvis CT Vulvar abscess and surrounding inflammation
Perineal sonography Diffuse hypoechogenicity
Increased dermal thickness
Diffusely elevated color doppler signal by local inflammation
Management Corticosteroid
Immunosupressant
Fig. 1 Bilateral vulvar swelling with abscess.Gross picture at the time 
of first visit: Bilateral swollen vulva with abscess-like discharge was 
noticed, although the patient has been undergone the I&D 3 times
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a follow-up MRI was performed because the features of 
the abscess were not typical of a gynecological abscess. 
A deep pelvic abscess, at a higher level than Bartholin 
abscess, was suspected. The MRI results showed dif-
fuse inflammation of the perineum around the posterior 
vaginal wall with abscess formation along both vestibular 
glands as well as both labia major and minor. There were 
also features suggestive of a rectovestibular fistula at the 
12–1 ‘o’clock position (Fig. 2B). The patient was then clin-
ically evaluated for Crohn’s disease because of the above 
MRI findings. Her laboratory tests, including inflamma-
tory markers, were normal.
The patient was then referred to the pediatric gastroen-
terology department where she underwent further blood 
tests, gastroduodenoscopy, and colonoscopy to rule out 
other differential diagnoses, such as sarcoidosis, pyo-
derma gangrenosum, hiradenitis suppurativa, cellulitis, 
tuberculosis, and contact dermatitis. Stool calprotectin 
levels was elevated to > 300 µg/g, which suggested a diag-
nosis of inflammatory bowel disease. A more detailed 
Fig. 2 MRI image showing vulvar abscess. A Axial view of pelvic MRI prior to I&D at previous hospital with soft tissue infiltration and enhancement 
in both labia major and perineum (arrow: soft tissue inflammation and swelling with abscess). B Follow-up MRI taken 6 weeks postoperatively at our 
institution (arrow: abscess)
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history revealed that the patient had no history of diar-
rhea or hematochezia. On gastroduodenoscopy, gastric 
mucosa was noted to be erythematous which was sugges-
tive of reflux esophagitis and chronic superficial gastri-
tis. Colonoscopy revealed multiple ulcers on the mucosa 
of the terminal ileum and the rectum (Fig.  3). Patho-
logical evaluation of tissue specimen retrieved showed 
mild chronic superficial gastritis and ulceration with 
ill-defined noncaseating granulomatous lesions in the 
mucosa of the terminal ileum, which were consistent with 
a diagnosis of Crohn’s disease or tuberculosis. Further 
AFB staining and Tb-PCR performed on biopsy samples 
taken from the terminal ileum were negative, which ruled 
out tuberculosis. The rectal biopsy specimen was within 
normal limits. The simple endoscopic score for Crohn’s 
disease was 11 [13]. The result of the stool culture was 
positive for Clostridium difficile and the patient received 
oral metronidazole therapy.
MRI enterography after oral contrast ingestion showed 
segmental and uneven wall thickening with ulcerative 
lesions from the distal to the terminal ileum and distal 
rectum with increased mucosal enhancement and dif-
fusion restriction (Fig.  4). Diffuse bilateral perineal soft 
tissue infiltration and increased enhancement with fea-
tures suggestive of a rectovaginal (11 ‘o’clock) and a vagi-
noperineal (bilateral anterior) fistula were also observed. 
The abscess in both vestibular glands and both labia were 
smaller in size compared to those in the pelvic MRI per-
formed the previous month at the gynecology depart-
ment. The Pediatric Crohn’s Disease Activity Index 
(PCDAI) was 12.5, which indicated clinical response 
(≤ 12.5), but not inactive disease (< 10) [14]. The modified 
PCDAI score was 2.5, indicating remission (< 7.5) [15].
She was placed on elemental diet (2000  kcal/day) 
four times daily for 12 weeks, azathioprine 50 mg daily, 
and mesalazine 1  g three times daily. Azathioprine was 
increased to 75 mg daily after three weeks. The elemen-
tal diet was stopped after the prescribed 12 weeks, and 
she was maintained on 75 mg daily of azathioprine. The 
vulvar lesion completely resolved and her white blood 
cell (WBC) count was 3470/µL during her follow-up visit 
after 6 weeks of treatment. Inflammatory markers were 
normal, and the PCDAI was 10. Oral Azathioprine was 
increased to 100 mg daily, with continuous WBC moni-
toring on follow-up.
The patient revisited the emergency room with vul-
var pain after taking medication for Crohn’s disease for 
10 weeks. On examination, there was right labia major 
swelling, tenderness, and pus discharge (Fig.  5). She 
underwent a Seton procedure for rectovaginal fistula 
(Fig. 6). While her symptoms initially improved, a recur-
rence required second operation. About 4 months after 
re-operation, her symptoms finally resolved.
Discussion and conclusion
VCD is a rare manifestation of metastatic CD in which 
inflammatory granulomatous lesions are separated from 
the gastrointestinal tract [4]. It manifests frequently as 
vulvar edema, ulcers, and fissures. Vulvar symptoms 
may be the first and only symptom of such patients [6]. 
Unfortunately, VCD is an uncommon presentation of 
Crohn’s disease, and not all patients present with active 
Fig. 3 Crohn’s ulcers on colonoscopy. Multiple ulcers were seen on 
terminal ileum mucosa
Fig. 4 MR enterography. Coronal view of the patient’s MRI 
enterography with segmental and uneven wall thickening of 
ulcerative lesions in distal to terminal ileum (arrow)
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gastrointestinal disease, and this leads to delays in mak-
ing the right diagnosis [6, 16]. Less than 200 cases of 
VCD have been published so far [7–9, 17]. These cases 
of VCD are usually accompanied by gastrointestinal fistu-
las, but most do not undergo gastrointestinal evaluation 
when they do not present with recognizable gastrointes-
tinal symptoms [18–20]. They are usually diagnosed at 
adulthood, with a mean age at diagnosis of 34 years [4], 
and only a few cases have been diagnosed in children [10, 
21, 22].
Many differential diagnoses must be considered, 
including Behcet’s disease, cellulitis, pyogenic infec-
tions, hidradenitis suppurativa, sarcoidosis, tuberculo-
sis, foreign body reactions, contact dermatitis, acquired 
lymphangiectasia, and sexual abuse before a diagnosis of 
VCD can be made [10]. Results of pathological evaluation 
of gastrointestinal biopsy specimens are vital in mak-
ing a diagnosis of VCD. Not every patient with vulvar 
symptoms should undergo gastroduodenoscopy or colo-
noscopy as a routine work-up; however, it should be con-
sidered in patients with atypical disease features. In VCD 
patients, pelvis MRI or anorectal endoscopic ultrasound 
may be helpful to identify rectovaginal fistula complex. In 
our case, we could see rectovaginal fistula on pelvic MRI 
and abscess was located higher, deeper than usual abscess 
from gynecologic origin. Moreover, in recurrent vulvar 
abscess with rectovaginal fistula combined to VCD, vul-
var malignancy should be excluded by biopsy as well. In 
some VCD cases, vulvar cancer rising from recurrent 
abscess with fistula was reported. In our case, histologic 
report from vulvar abscess revealed acute and chronic 
inflammation, which helped to exclude malignancy even-
tually. Although a diagnosis of VCD is made, if recurrent 
vulvar abscess develops still, the patient should be moni-
tored and informed about the possibility of malignancy at 
her vulvar lesion [20, 23, 24].
In current case, the patient had no gastrointestinal 
symptoms, but vulvar symptoms only. She had few event 
of loose stool or diarrhea, irritable bowel symptom. The 
strength of our report includes that focal vulvar abscess 
which does not respond to the conventional treatment, 
although patient has none of bowel symptoms, Crohn’s 
disease must be included for the differential diagnosis. 
The atypical manifestation of VCD without gastrointesti-
nal symptom is unique for our case report.
The treatment of VCD focuses on the standard treatment 
of Crohn’s disease, such as corticosteroids, metronidazole, 
and azathioprine, which has been observed to result in 
varying degrees of success in treating vulvar lesions [2]. The 
diagnosis of VCD may be delayed and the disease might 
not be properly treated; therefore, tumor necrosis factor-ɑ 
inhibitors, such as infliximab, have been recommended for 
the treatment of refractory vulvar symptoms [6, 16]. Early 
diagnosis and treatment are key, as delayed treatment may 
lead to permanent vulvar distortions and decreased quality 
of life. Surgical treatment may be considered as a last resort 
Fig. 5 Improvement of vulvar lesion after medical treatment of 
Crohn’s disease.Vulvar swelling is remained slightly, but abscess has 
been almost resolved after starting azathioprine treatment
Fig. 6 Changes of vulvar lesion after recto-vaginal fistula treatment.
Seton procedure was performed to treat rectovaginal fistula, which 
caused sustained inflammation of vulvar area
Page 6 of 6Kim et al. BMC Women’s Health          (2021) 21:316 
if the vulvar lesions do not respond to medical treatment; 
however, this frequently results in localized recurrence [5, 
9].
The management of VCD is challenging as it is a rare 
disease with nonspecific symptoms, that requires close 
cooperation from gynecologists, dermatologists, and gas-
troenterologists alike [3]. Our experience reported in this 
case report should guide gynecologists to consider and sus-
pect a vulvar presentation of CD in cases of unexplained 
vulvar inflammatory lesions that are unresponsive to anti-
biotics or surgical treatment.
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